Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CTSL | P07711 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22304086 | 0.87 | MEN1 (0.49) | KMT2AMEN1 | |
| SCHEMBL22338701 | 0.87 | MEN1 (0.49) | KMT2AMEN1 | |
| SCHEMBL7258072 | 0.79 | KMT2A (0.51) | KMT2AMEN1ALDH1A1KCNJ1KCNH2 | |
| SCHEMBL2603379 | 0.78 | TSHR (0.49) | KMT2AMEN1ALDH1A1KCNJ1KCNH2 | |
| SCHEMBL5692057 | 0.78 | ALDH1A1 (0.50) | KMT2AMEN1ALDH1A1MAPTRAB9A | |
| SCHEMBL22285567 | 0.76 | CA2 (0.58) | KMT2AMEN1ALDH1A1MAPTRAB9A | |
| SCHEMBL22285568 | 0.76 | CA2 (0.58) | KMT2AMEN1ALDH1A1MAPTRAB9A | |
| SCHEMBL7060664 | 0.76 | TSHR (0.47) | KMT2AMEN1ALDH1A1KCNJ1KCNH2 | |
| SCHEMBL18569695 | 0.75 | MEN1 (0.47) | KMT2AMEN1 | |
| SCHEMBL19762722 | 0.74 | ALDH1A1 (0.47) | KMT2AMEN1ALDH1A1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230053746-A1 | IL-17 LIGANDS AND USES THEREOF | DICE MOLECULES SV, INC. | 2023-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230053746-A1 | IL-17 LIGANDS AND USES THEREOF | IL17A, IL2, IL15 | KMT2A 4343/4885MEN1 2700/4885ALDH1A1 951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.